Mankind Pharma
MANKIND.NSApprovedMankind Pharma Limited is one of India's largest pharmaceutical companies by domestic sales, founded in 1991 and headquartered in New Delhi. The company focuses on developing, manufacturing, and marketing branded generic formulations across diverse therapeutic segments. With a strong presence in the Indian pharmaceutical market and growing international footprint, Mankind Pharma went public in 2023 and continues to expand its product portfolio and market reach through strategic acquisitions and partnerships.
MANKIND.NS · Stock Price
Historical price data
AI Company Overview
Mankind Pharma Limited is one of India's largest pharmaceutical companies by domestic sales, founded in 1991 and headquartered in New Delhi. The company focuses on developing, manufacturing, and marketing branded generic formulations across diverse therapeutic segments. With a strong presence in the Indian pharmaceutical market and growing international footprint, Mankind Pharma went public in 2023 and continues to expand its product portfolio and market reach through strategic acquisitions and partnerships.
Technology Platform
Branded generic pharmaceutical manufacturing and development platform with capabilities across multiple dosage forms including oral solids, injectables, and topical formulations.
Pipeline Snapshot
22 drugs in pipeline, 1 in Phase 3
| Drug | Indication | Stage |
|---|---|---|
| Test - Bimatoprost 0.01% Ophthalmic Solution + Reference - LUMIGAN® (Bimatoprost... | Glaucoma, Open-Angle | Phase 3 |
| MKP10241 + Placebo | Type 2 Diabetes Mellitus (T2DM) | Phase 2 |
Funding History
1FDA Approved Drugs
1Opportunities
Risk Factors
Competitive Landscape
Competes with major Indian pharma companies like Sun Pharma, Cipla, and Dr. Reddy's, but differentiates through strong domestic branded generics focus, established brand portfolio, and extensive distribution network rather than export-focused generic strategies.
Company Info
Trading
Contact
Therapeutic Areas
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile